Search Results – Inserm Transfert

Our Technology Offers

Welcome to our Technology Offers website

You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.

BIO13284-T1

Drug Field of development:

Transplantation Therapy Area:

Method Type of patent:

Methods for expanding a population of alveolar macrophages in a long

The present invention relates to methods for expanding a population of alveolar macrophages in a long term culture. In particular, an object of the […]

BIO1508601 -T1

Drug Field of development:

Immunology Therapy Area:

Target Type of patent:

Nanobody against ela2a to treat inflammatory bowel diseases (ibd) or

The invention is in the field of therapy of gut inflammatory diseases such as Inflammatory Bowel Diseases (IBD) or Irritable Bowel Syndrome (IBS) […]

BIO18315-T1

Drug Field of development:

Immunology Therapy Area:

Product Type of patent:

Methods and compositions for treating asthma and allergic diseases

The present invention relates to allergy field. Several independent groups have recently investigated the implication of PCSK9 on inflammation and […]

BIO22067-T1

Drug Field of development:

Immunology Therapy Area:

Target Type of patent:

Use of tcr-deficient car-tregs in combination with anti-tcr complex

The present invention is defined by the claims. In particular, the present invention relates to the use of TCR-deficient CAR-Tregs in combination with […]

BIO20418-T1

Drug Field of development:

Transplantation Therapy Area:

Method Type of patent:

Methods for the diagnosis and thetreatment of graft-versus-host

The invention relates to methods for the prediction and the treatment of risk of acute graft versus host disease. The inventors demonstrated that an […]

BIO18376-T1

Drug Field of development:

Immunology Therapy Area:

Target Type of patent:

Ivig composition and method of treatment of antibody deficient

The invention is in the field of therapy of antibody deficiencies such as immune diseases and inflammatory disorders. The inventors demonstrate for […]

BIO60360-T1

Drug Field of development:

Immunology Therapy Area:

Method Type of patent:

Fc-engineered anti-human ige antibodies and methods of use

The present invention relates to the treatment of IgE-mediated disease. The inventors hypothesized that formation of immune complexes between […]

BIO17668-T1

Drug Field of development:

Immunology Therapy Area:

Methods for modulating innate lymphoid cell activity, antibody drug

The present invention relates to methods for modulating innate lymphoid cell activity, antibody drug conjugates and uses in therapy. The inventors […]

BIO14401-T1

Drug Field of development:

Systemic Lupus Erythematosus Therapy Area:

Product Type of patent:

Ptgdrs, cxcr4 and basophils in systemic lupus erythematosus

The present invention relates to PTGDRs, CXCR4 and Basophils to treat in Systemic Lupus Erythematosus. In particular, the present invention concerns a […]

BIO17218-T1

Drug Field of development:

Transplantation Therapy Area:

Target Type of patent:

Antagonists of il-33 for use in methods for preventing ischemia

Inflammation is a prominent feature of ischemia-reperfusion injury (IRI) characterized by leukocyte infiltration and renal tubular injury. However, […]

147

56

310

46

Our Technology Offers

Methods for expanding a population of alveolar macrophages in a long

Nanobody against ela2a to treat inflammatory bowel diseases (ibd) or

Methods and compositions for treating asthma and allergic diseases

Use of tcr-deficient car-tregs in combination with anti-tcr complex

Methods for the diagnosis and thetreatment of graft-versus-host

Ivig composition and method of treatment of antibody deficient

Fc-engineered anti-human ige antibodies and methods of use

Methods for modulating innate lymphoid cell activity, antibody drug

Ptgdrs, cxcr4 and basophils in systemic lupus erythematosus

Antagonists of il-33 for use in methods for preventing ischemia

You might also be interested in

Novel melanoma antigens

Nanobody against ela2a to treat inflammatory bowel

Transoesophageal device using high intensity

Recombinant flagellin for preventing and treating

Methods for expanding a population of alveolar

Use of il-36 inhibitors for the treatment of

Medical device for olfactory stimulation

Antigenic peptides deriving from urocortin 3 and

Pyk2-based gene therapy gene therapy attenuates

Methods and composition to identify and treat

Anti-neurotensin mab for the treatment of cancer

Triarylpyridine compounds and use thereof for